{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Plasma+sample+collection", "query": { "intervention": "Plasma sample collection" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 154, "total_pages": 16, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Plasma+sample+collection&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-21T04:12:27.771Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02481869", "title": "Platelet Rich Plasma Injection in Pilon Fractures", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Fracture" ], "interventions": [ { "name": "Arthrocentesis/PRP", "type": "BIOLOGICAL" }, { "name": "Arthrocentesis/Saline", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "University of Missouri-Columbia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 11, "start_date": "2015-06", "completion_date": "2019-11", "has_results": true, "last_update_posted_date": "2021-02-05", "last_synced_at": "2026-09-21T04:12:27.771Z", "location_count": 1, "location_summary": "Columbia, Missouri", "locations": [ { "city": "Columbia", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT02481869" }, { "nct_id": "NCT07723651", "title": "[18F]Fluorthanatrace - Positron Emission Tomography (FTT-PET) and ctDNA to Predict Response to PARP Inhibitor Therapy in Metastatic Prostate Cancer (mPC)", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Metastatic Prostate Cancer", "Prostate Cancer" ], "interventions": [ { "name": "1-(4-(2-Fluoroethoxy)phenyl)-8,9-dihiydro-2,7,9a-triazabenzo[cd]azulen-6(7H)-one", "type": "DRUG" }, { "name": "FTT-PET/CT", "type": "DEVICE" }, { "name": "EnhanceAR-Seq", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DRUG", "DEVICE", "DIAGNOSTIC_TEST" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 75, "start_date": "2026-09-01", "completion_date": "2032-03-31", "has_results": false, "last_update_posted_date": "2026-07-23", "last_synced_at": "2026-09-21T04:12:27.771Z", "location_count": 3, "location_summary": "St Louis, Missouri • Philadelphia, Pennsylvania • Houston, Texas", "locations": [ { "city": "St Louis", "state": "Missouri" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07723651" }, { "nct_id": "NCT06775041", "title": "Study to Determine Optimal Dose and Evaluate Safety, Tolerability, and Pharmacokinetics of Progerinin in Patients With Hutchinson-Gilford Progeria Syndrome (HGPS)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hutchinson-Gilford Progeria Syndrome" ], "interventions": [ { "name": "Progerinin", "type": "DRUG" }, { "name": "Lonafarnib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "PRG Science & Technology Co., Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": null, "sex": "ALL", "summary": "1 Year and older" }, "enrollment_count": 10, "start_date": "2025-01-13", "completion_date": "2026-03", "has_results": false, "last_update_posted_date": "2026-02-09", "last_synced_at": "2026-09-21T04:12:27.771Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06775041" }, { "nct_id": "NCT02014415", "title": "Alpha-1 Antitrypsin Deficiency Adult Liver Study", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Alpha-1 Antitrypsin Deficiency" ], "interventions": [ { "name": "Liver Biopsy (Biopsy Group Only)", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "St. Louis University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 120, "start_date": "2013-12", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2026-04-27", "last_synced_at": "2026-09-21T04:12:27.771Z", "location_count": 3, "location_summary": "San Diego, California • Boston, Massachusetts • St Louis, Missouri", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT02014415" }, { "nct_id": "NCT02871050", "title": "Castleman Disease Collaborative Network Biobank", "overall_status": "WITHDRAWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Castleman Disease", "Castleman's Disease", "Giant Lymph Node Hyperplasia", "Angiofollicular Lymph Hyperplasia", "Angiofollicular Lymph Node Hyperplasia", "Angiofollicular Lymphoid Hyperplasia", "GLNH", "Hyperplasia", "Giant Lymph Node" ], "interventions": [ { "name": "Sample Collection", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Castleman Disease Collaborative Network", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 0, "start_date": "2016-06", "completion_date": "2018-06", "has_results": false, "last_update_posted_date": "2018-07-31", "last_synced_at": "2026-09-21T04:12:27.771Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02871050" }, { "nct_id": "NCT06532279", "title": "Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8", "Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8", "Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8", "Head and Neck Squamous Cell Carcinoma", "Hypopharyngeal Squamous Cell Carcinoma", "Laryngeal Squamous Cell Carcinoma", "Nasopharyngeal Squamous Cell Carcinoma", "Oral Cavity Squamous Cell Carcinoma", "Oropharyngeal Squamous Cell Carcinoma", "Stage 0 Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8", "Stage 0 Hypopharyngeal Carcinoma AJCC v8", "Stage 0 Nasopharyngeal Carcinoma AJCC v8", "Stage 0 Oropharyngeal (p16-Negative) Carcinoma AJCC v8", "Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8", "Stage I Hypopharyngeal Carcinoma AJCC v8", "Stage I Laryngeal Cancer AJCC v8", "Stage I Lip and Oral Cavity Cancer AJCC v8", "Stage I Nasopharyngeal Carcinoma AJCC v8", "Stage I Oropharyngeal (p16-Negative) Carcinoma AJCC v8", "Stage II Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8", "Stage II Hypopharyngeal Carcinoma AJCC v8", "Stage II Laryngeal Cancer AJCC v8", "Stage II Lip and Oral Cavity Cancer AJCC v8", "Stage II Nasopharyngeal Carcinoma AJCC v8", "Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8", "Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8", "Stage III Hypopharyngeal Carcinoma AJCC v8", "Stage III Laryngeal Cancer AJCC v8", "Stage III Lip and Oral Cavity Cancer AJCC v8", "Stage III Nasopharyngeal Carcinoma AJCC v8", "Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8", "Stage IVA Hypopharyngeal Carcinoma AJCC v8", "Stage IVA Laryngeal Cancer AJCC v8", "Stage IVA Lip and Oral Cavity Cancer AJCC v8", "Stage IVA Nasopharyngeal Carcinoma AJCC v8", "Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8", "Stage IVB Hypopharyngeal Carcinoma AJCC v8", "Stage IVB Laryngeal Cancer AJCC v8", "Stage IVB Lip and Oral Cavity Cancer AJCC v8", "Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8", "Stomatitis" ], "interventions": [ { "name": "Best Practice", "type": "OTHER" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Cisplatin", "type": "DRUG" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Image Guided Radiation Therapy", "type": "RADIATION" }, { "name": "Intensity-Modulated Radiation Therapy", "type": "RADIATION" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "MnSOD Mimetic BMX-001", "type": "DRUG" }, { "name": "Placebo Administration", "type": "DRUG" }, { "name": "Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "OTHER", "PROCEDURE", "DRUG", "RADIATION" ], "sponsor": "NRG Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 98, "start_date": "2025-06-23", "completion_date": "2032-01-01", "has_results": false, "last_update_posted_date": "2026-08-17", "last_synced_at": "2026-09-21T04:12:27.771Z", "location_count": 153, "location_summary": "Gilbert, Arizona • Peoria, Arizona • Phoenix, Arizona + 126 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Surprise", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT06532279" }, { "nct_id": "NCT05201833", "title": "TRACK-TBI Longitudinal Biomarker Study", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Traumatic Brain Injury" ], "interventions": [ { "name": "Telephone Outcome Assessment", "type": "BEHAVIORAL" }, { "name": "In-Person Outcome Assessment", "type": "BEHAVIORAL" }, { "name": "3T Magnetic Resonance Imaging (MRI)", "type": "PROCEDURE" }, { "name": "Blood Draw", "type": "PROCEDURE" } ], "intervention_types": [ "BEHAVIORAL", "PROCEDURE" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 300, "start_date": "2022-03-01", "completion_date": "2027-02-28", "has_results": false, "last_update_posted_date": "2026-08-17", "last_synced_at": "2026-09-21T04:12:27.771Z", "location_count": 11, "location_summary": "San Francisco, California • Charlestown, Massachusetts • Cincinnati, Ohio + 8 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Charlestown", "state": "Massachusetts" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT05201833" }, { "nct_id": "NCT04929015", "title": "Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study)", "overall_status": "SUSPENDED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Appendix Carcinoma by AJCC V8 Stage", "Colorectal Carcinoma by AJCC V8 Stage", "Digestive System Neoplasm", "Esophageal Carcinoma by AJCC V8 Stage", "Gastric Carcinoma by AJCC V8 Stage", "Liver and Intrahepatic Bile Duct Carcinoma", "Peritoneal Carcinomatosis" ], "interventions": [ { "name": "Biospecimen Collection - blood and tissue sample collection", "type": "PROCEDURE" }, { "name": "Electronic Health Record Review", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "OTHER" ], "sponsor": "Rutgers, The State University of New Jersey", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2021-04-29", "completion_date": "2027-09-01", "has_results": false, "last_update_posted_date": "2026-05-04", "last_synced_at": "2026-09-21T04:12:27.771Z", "location_count": 2, "location_summary": "Livingston, New Jersey • New Brunswick, New Jersey", "locations": [ { "city": "Livingston", "state": "New Jersey" }, { "city": "New Brunswick", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT04929015" }, { "nct_id": "NCT05148117", "title": "Mitochondrial Dysfunction Contributes to Sepsis Induced Cardiac Dysfunction", "overall_status": "WITHDRAWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Sepsis" ], "interventions": [ { "name": "Suspected Sepsis Group - Diagnostic Measurements", "type": "DIAGNOSTIC_TEST" }, { "name": "Control Group - Diagnostic Measurements", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2025-12-10", "completion_date": "2026-01-14", "has_results": false, "last_update_posted_date": "2026-02-20", "last_synced_at": "2026-09-21T04:12:27.771Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT05148117" }, { "nct_id": "NCT06227819", "title": "BVA-200 vs BVA-100 Validation Study", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Heart Failure", "High Blood Pressure", "High Cholesterol", "Anemia", "Diabetes", "Thyroid Diseases", "Kidney Diseases", "Clotting Disorder", "Trauma", "Other Disease" ], "interventions": [ { "name": "BVA-200", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Daxor Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 62, "start_date": "2023-05-23", "completion_date": "2023-11-30", "has_results": false, "last_update_posted_date": "2024-01-29", "last_synced_at": "2026-09-21T04:12:27.771Z", "location_count": 1, "location_summary": "Oak Ridge, Tennessee", "locations": [ { "city": "Oak Ridge", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT06227819" } ] }